Maartje V.
- Country
- The Netherlands
- Department
- Oncology center
Research Overview
- Adjuvant Pembrolizumab Versus Capecitabine or Olaparib in Patients with Early-Stage Triple-Negative Breast Cancer with Residual Disease Following Neoadjuvant Therapy
- Evaluation of CDK4/6 Inhibitors Abemaciclib, Palbociclib, and Ribociclib in HR+/HER2- Metastatic Breast Cancer: A Randomized Clinical Trial
- A Phase II, Multicenter, Randomized, Double-Blind Study of Tobemstomig/RO7247669 Combined with Nab-Paclitaxel Compared with Pembrolizumab Combined with Nab-Paclitaxel in Participants with Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer
Data & Insights
Has run more than one trial at 63 of 91 partner sites.
Specializations
Breast Cancer Treatment
The investigator specializes in advancing treatment options for metastatic breast cancer, with particular focus on developing innovative therapeutic approaches for triple negative breast cancer (TNBC).
- Advanced Treatment Strategies
- Biomarker Research
- Targeted Therapies
Expertise extends to investigating novel combination therapies and treatment optimization for advanced disease stages.
Hormone Receptor Research
The investigator focuses on developing treatment strategies for hormone receptor-positive breast cancer, particularly exploring the effectiveness of endocrine therapy combinations.
- Endocrine Therapy Optimization
- CDK4/6 Inhibition Studies
- Sequential Treatment Approaches
Research encompasses first-line and second-line treatment strategies for hormone receptor-positive/HER2-negative disease.
Precision Medicine
The investigator's work centers on personalized treatment approaches, incorporating biomarker validation and targeted therapeutic strategies.
- BRCA1-like Testing
- Treatment Response Prediction
- Progressive Disease Management
Focus includes developing predictive tools for treatment response and optimizing therapeutic sequences.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.